Article

Sunday, November 12, 2006 5:00 PM - 9:00 PM

An evening CME Symposium and Reception

A CME Symposium and Reception held
during the AAO 2006
Joint Meeting

Sunday, November 12, 2006
5:00 PM to 9:00 PM
The Venetian Resort Hotel Casino
Madame Tussaud's Wax Museum
3355 Las Vegas Blvd S
Las Vegas, Nevada

REGISTER ON LINE
OR CALL TOLL FREE
888-248-0036

Program Chairman and Moderator

Richard K. Parrish II, MDProfessor, Department of Ophthalmology
Associate Dean for Graduate Medical Education

Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida

Faculty

Donald L. Budenz, MD, MPHProfessor of Ophthalmology, Epidemiology, and Public Health
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida

David S. Greenfield, MDProfessor of Ophthalmology
Bascom Palmer Eye Institute of the Palm Beaches
University of Miami School of Medicine
Palm Beach Gardens, Florida

Steven L. Mansberger, MD, MPHAdjunct Assistant Professor of Ophthalmology
Oregon Health Science University
Director, Glaucoma Service
Veteran's Hospital
Clinical Assistant Professor of Public Health and Preventive Medicine
Oregon Health Science University
Portland, Oregon

Felipe A. Medeiros, MDAssistant Professor of Ophthalmology
Hamilton Glaucoma Center
University of California, San Diego
La Jolla, California

Target Audience
This educational activity is intended for comprehensive ophthalmologists, glaucoma specialists, and resident ophthalmologists.

Statement of Need and Program Description
The ability to accurately diagnose glaucoma and identify patients at risk has evolved significantly in the past couple of years, providing physicians with improvements in managing the condition. High intraocular pressure (IOP) has been a standard diagnostic marker for primary open-angle glaucoma. However, we have seen that some patients with high IOP never progress to glaucoma, and some patients with low or normal IOP develop glaucoma. This has prompted interest in looking at structural causes for glaucoma thereby increasing the need for ophthalmologists to better understand and use tools and devices that evaluate the optic nerve. The ability to identify those patients at risk has advanced as well with learning from the field of cardiology. New tools have been developed that clinicians need to learn to incorporate into practice. This symposium will present experts' recommendations for the best diagnostic and risk assessment tools and how treatment and overall patient management can be improved.

Learning Objectives
Upon completion of this activity, participants should be able to:

Agenda5:00 PM–6:00 PM—Attendee Registration at The Venetian
6:00 PM–6:05 PM–Welcome and Introduction

6:05 PM–6:20 PM—How Do You Judge Risk, Learnings from EGPS
Steven L. Mansberger, MD, MPH

6:20 PM–6:35 PM—Diurnal and Long-term IOP Fluctuations
Felipe A. Medeiros, MD

6:35 PM–6:50 PM—Diagnosing Glaucoma Progression with Visual Fields
Donald L. Budenz, MD, MPH

6:50 PM–7:05 PM—OCT, GDX, HRT, and Judging Risk of Progression
David S. Greenfield, MD

7:05 PM–7:20 PM—The Meaning of Risk Assessment: Putting It All Together
Richard K. Parrish II, MD

7:20 PM–7:30 PM—Q&A Session

7:30 PM–9:00 PM—Reception at Madame Tussaud's Wax Museum

Accreditation Statement
This continuing medical education activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The New York Eye and Ear Infirmary and cme2, an independent subsidiary of Advanstar Communications Inc, publisher of Ophthalmology Times. The New York Eye and Ear Infirmary is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The New York Eye and Ear Infirmary designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement
The New York Eye and Ear Infirmary requires that each participant/teacher in a CME-accredited educational activity disclose the existence of any financial interest and/or other relationship(s) (eg, paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation. Speakers are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity. The disclosed information in no way presumes to assess the participant's qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or perceived, which is related to a specific event. Full disclosure of faculty and commercial relationships, if any, will be made at the program.

Provider Disclosure
The New York Eye and Ear Infirmary received a financial benefit from Pfizer Ophthalmics to administer this educational activity.

PRE-REGISTER ON LINE
or call 888-248-0036
or 218-740-7130

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.